25 May 2013
Keywords: pharmos, begin, ph, ii, neuroprotector, corporation, israel
Article | 25 November 1996
Pharmos Corporation of Israel has received approval from the Israeli
Minister of Health to commence a Phase II study with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 November 1996
18 November 1996
24 May 2013
© 2013 thepharmaletter.com